Table 4.
Estimated HR for Incident Prehypertension/Hypertension by VMS Categories, 1353 Women Normotensive at Baseline
| Unadjusted | HR (95% CI) | p | No. observations/No. events |
|---|---|---|---|
| None | Reference | 0.0001 | 6385/620 |
| 1–5 days | 1.22 (1.01, 1.48) | ||
| 6+ days | 1.62 (1.30, 2.03) | ||
| Model 1 | |||
| None | Reference | 0.0024 | 6385/620 |
| 1–5 days | 1.20 (0.98, 1.46) | ||
| 6+ days | 1.50 (1.19, 1.89) | ||
| Model 2 | |||
| None | Reference | 0.0443 | 6257/589 |
| 1–5 days | 1.08 (0.87, 1.33) | ||
| 6+ days | 1.39 (1.08, 1.79) | ||
VMS was assessed concurrently with each visit and VMS was treated as a time-varying covariate. Unadjusted: model includes only current VMS frequency and time since baseline; Model 1: adjusted for baseline age and site; Model 2: variables including in Model 1, race, education level, current menopausal status, baseline parity, baseline alcohol consumption, baseline physical activity, current smoking status, current anxiety score, current BMI; Prehypertension (SBP 120–139 mmHg or DBP 80–89 mmHg); hypertension (use of an antihypertensive agent or SBP ≥140 mmHg or DBP ≥90 mmHg) per JNC VII.
HR, hazard ratio.